This memorandum of understanding is between Antivenin Research Labs and Kenya Snakebite Research & Intervention Centre to analyze two anti-venoms - SBE ELixa Polyvalent anti-venom and SB Supervalent Anti-venom. Antivenin Research Labs will provide samples of SBE ELixa for testing, procure volunteers for clinical trials, provide cases where SBE ELixa saved lives, and liaise with KEMRI for commercialization. Kenya Snakebite Research & Intervention Centre will conduct ELISA tests on SBE ELixa and supply fresh venom for black mambas and cobras.
This memorandum of understanding is between Antivenin Research Labs and Kenya Snakebite Research & Intervention Centre to analyze two anti-venoms - SBE ELixa Polyvalent anti-venom and SB Supervalent Anti-venom. Antivenin Research Labs will provide samples of SBE ELixa for testing, procure volunteers for clinical trials, provide cases where SBE ELixa saved lives, and liaise with KEMRI for commercialization. Kenya Snakebite Research & Intervention Centre will conduct ELISA tests on SBE ELixa and supply fresh venom for black mambas and cobras.
This memorandum of understanding is between Antivenin Research Labs and Kenya Snakebite Research & Intervention Centre to analyze two anti-venoms - SBE ELixa Polyvalent anti-venom and SB Supervalent Anti-venom. Antivenin Research Labs will provide samples of SBE ELixa for testing, procure volunteers for clinical trials, provide cases where SBE ELixa saved lives, and liaise with KEMRI for commercialization. Kenya Snakebite Research & Intervention Centre will conduct ELISA tests on SBE ELixa and supply fresh venom for black mambas and cobras.
2. Submission of the findings to Kenya Medical Research Institute
and any other institution that we have standing and future agreements
BACKGROUND
Patrick Musilu, An Analyst and shareholder of Antivenin Research Labs
(ARL) was the first to contact Dr.George Oluoch of KSRIC on Oct 29, 2020, 5:05 PM by an email. Through the letter, we sought partnerships in the distribution/clinical trials of a venom based anti-venom of indigenous origin. Sure of the efficacy of our antivenin, we little knew of the regulations that govern the sale of drugs but have since evolved. Since October 29th 2020, we have sent a total of 9 emails some which include the full of our we make the antivenom. We have sent emails of copies of emails other institutions on issues regarding SBE ELixa, latest which was to Kenya Wildlife Services.
In our conversation with Dr. Oluoch on the 26th November 2021, We
discussed;
1.SBE ELixa is a departure from Albert Calmette paradigm of
vaccines being the only cure to envenoming. Our theory that Venom is not poison when swallowed but a digestible protein. The antidote effectively stops SBE from multiple species of snakes.
2. Permission/Letter of No Objection to our use of Venom. Venom is
a wildlife resources
3. We submitted samples of of the compound in a bottle Dr. Oluoch
for commencement of an ELISA test
4. The payment of Kshs.100,000 to cover material cost of the
experiments by Antivenin Research Labs to KSRIC upon submission of the results to Kenya Medical Research Institute
Antivenin Research Labs
Responsibilities under this MOU
1. Provision of samples of SBE ELixa. Time Tag 12 Hours
2. Procuring volunteers for clinical trials. Time tag 72 Hours 3. Procuring casualties whose lives were saved by SBE ELixa Time tag 72 Hours 4. Liaise with KEMRI for possible incubation of the project commercialization and launch Time tag 72 Hours
Kenya Snakebite Research & Intervention Centre
Responsibilities under this MOU
1. Conducting ELISA test on SBE ELIxa compound Time Tag ----Hrs
2. Supply of fresh venom for Black Mamba and Cobra ------Hrs